← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2010Last known activity
Dec 30, 2025
Timeline
1730s
- Jan 1, 1732
Universidad de Guanajuato— Founded
Drugs by trial phase (33 distinct, 28 trials)
Phase 4 (8 own, 0 via acquisition)
Phase 3 (12 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (9 own, 0 via acquisition)
Indications
Recent trials (50)
- NCT07297589OfficialPhase 3Dec 30, 2025
- NCT07295223OfficialPhase 3Dec 15, 2025
- NCT07295223CollaboratorPhase 3Dec 15, 2025
- NCT07149506Sponsor investigatorPhase 3Sep 1, 2025
- NCT07149506Lead sponsorPhase 3Sep 1, 2025
- NCT07149506CollaboratorPhase 3Sep 1, 2025
- NCT05778266Overall official - principal investigatorN/AMar 14, 2023
- NCT05778266Reponsible party - principal investigatorN/AMar 14, 2023
- NCT05778266Study chairN/AMar 14, 2023
- NCT05778266Lead sponsorN/AMar 14, 2023
- NCT05595447CollaboratorPhase 2/Phase 3Oct 18, 2022
- NCT05162001Overall official - principal investigatorEarly Phase 1Nov 21, 2021
- NCT05162001Lead sponsorEarly Phase 1Nov 21, 2021
- NCT05162001Reponsible party - principal investigatorEarly Phase 1Nov 21, 2021
- NCT04871360Reponsible party - principal investigatorN/AMay 5, 2021
Details
- Founded
- Guanajuato, MX Jan 1, 1732
- Last known activity
- Dec 30, 2025